The fetal aspects of Tay-Sachs disease.
D000032:Abortion, Therapeutic; D000649:Amniocentesis; D000650:Amnion; D001923:Brain Chemistry; D002855:Chromatography, Thin Layer; D005227:Fatty Acids / Q000032:analysis; D005260:Female; D005333:Fetus / Q000201:enzymology / Q000378:metabolism*; D005732:Gangliosides / Q000032:analysis* / Q000378:metabolism; D006596:Hexosaminidases / Q000032:analysis; D006801:Humans; D002479:Inclusion Bodies; D007585:Jews; D008064:Lipidoses / Q000175:diagnosis* / Q000378:metabolism / Q000517:prevention & control; D008661:Metabolism, Inborn Errors / Q000175:diagnosis; D009474:Neurons / Q000166:cytology; D011247:Pregnancy; D011677:Punctures; D011689:Purkinje Cells / Q000166:cytology; D013110:Sphingosine / Q000032:analysis
D005227:Fatty Acids; D005732:Gangliosides; D006596:Hexosaminidases; D013110:Sphingosine